🇺🇸 Agonist GnRH Acetate Triptoreline in United States

Agonist GnRH Acetate Triptoreline (Agonist GnRH Acetate Triptoreline) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Agonist GnRH Acetate Triptoreline in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Agonist GnRH Acetate Triptoreline approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Agonist GnRH Acetate Triptoreline in United States?

Instituto Valenciano de Infertilidad, IVI VALENCIA is the originator. The local marketing authorisation holder may differ — check the official source linked above.